Aflatoxin B1 metabolism (Equus caballus)

From WikiPathways

Jump to: navigation, search
1-6, 8, 107, 97, 9nonenzymaticDNA adductsnonenzymatic(pH-dependent)Aflatoxin B1 C6-monoaldehydeAflatoxin Q1GSTM1Aflatoxin M1XP_001493936.1Aflatoxin B1 C8-monoaldehydeAflatoxin B1 C6-monoalcoholAflatoxin B1 C8-monoalcoholAflatoxin B1 dialdehydeAflatoxin M1 epoxideCYP2A13XP_001493936.1Aflatoxin B1 exo-8,9-epoxide-GSHXP_001493936.1XP_001917301.1Aflatoxin B1-6,8-dialcoholAflatoxin B1 exo-8,9-epoxideAflatoxin-endo-B1-8,9-epoxideaflatoxin B1CYP2A13AKR7A2Aflatoxin B1 8,9-dihydrodiolXP_001489035.1XP_001489453.1CYP3A4CYP3A4


Description

Aflatoxins are naturally occurring mycotoxins that are produced by many species of Aspergillus, a fungus, most notably Aspergillus flavus and Aspergillus parasiticus. After entering the body, aflatoxins are metabolized by the liver to a reactive intermediate, aflatoxin M1, an epoxide. Aflatoxin B1 is considered the most toxic and is produced by both Aspergillus flavus and Aspergillus parasiticus. Source: Wikipedia

Comments

HomologyConvert 
This pathway was inferred from Homo sapiens pathway WP699(r30253) with a 50% conversion rate.

Please use the New WikiPathways

View approved pathways at the new wikipathways.org. This website will shutdown soon.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Zhu LR, Thomas PE, Lu G, Reuhl KR, Yang GY, Wang LD, Wang SL, Yang CS, He XY, Hong JY; ''CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody.''; Drug Metab Dispos, 2006 PubMed Europe PMC Scholia
  2. Tiemersma EW, Omer RE, Bunschoten A, van't Veer P, Kok FJ, Idris MO, Kadaru AM, Fedail SS, Kampman E; ''Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.''; Cancer Epidemiol Biomarkers Prev, 2001 PubMed Europe PMC Scholia
  3. Stewart RK, Smith GB, Donnelly PJ, Reid KR, Petsikas D, Conlan AA, Massey TE; ''Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B(1) in human lung: differential cellular distribution and lack of significance of the GSTM1 genetic polymorphism.''; Carcinogenesis, 1999 PubMed Europe PMC Scholia
  4. Barski OA, Tipparaju SM, Bhatnagar A; ''The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.''; Drug Metab Rev, 2008 PubMed Europe PMC Scholia
  5. Jin Y, Penning TM; ''Aldo-keto reductases and bioactivation/detoxication.''; Annu Rev Pharmacol Toxicol, 2007 PubMed Europe PMC Scholia
  6. Guengerich FP; ''Cytochrome P450s and other enzymes in drug metabolism and toxicity.''; AAPS J, 2006 PubMed Europe PMC Scholia
  7. Guengerich FP, Arneson KO, Williams KM, Deng Z, Harris TM; ''Reaction of aflatoxin B(1) oxidation products with lysine.''; Chem Res Toxicol, 2002 PubMed Europe PMC Scholia
  8. Guengerich FP, Cai H, McMahon M, Hayes JD, Sutter TR, Groopman JD, Deng Z, Harris TM; ''Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases.''; Chem Res Toxicol, 2001 PubMed Europe PMC Scholia
  9. He XY, Tang L, Wang SL, Cai QS, Wang JS, Hong JY; ''Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract.''; Int J Cancer, 2006 PubMed Europe PMC Scholia
  10. Kensler TW, Qian GS, Chen JG, Groopman JD; ''Translational strategies for cancer prevention in liver.''; Nat Rev Cancer, 2003 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
136898view19:21, 26 February 2025KhanspersModified description
136892view19:18, 26 February 2025KhanspersModified description
106096view12:00, 16 August 2019MaintBotHMDB identifier normalization
68746view22:56, 6 July 2013MaintBotUpdated to 2013 gpml schema
67029view09:56, 26 June 2013Christine ChichesterOntology Term : 'aflatoxin metabolic pathway' added !
58879view00:33, 21 February 2013MaintBotUpdated Ensembl and UniProt data source
57154view13:15, 23 January 2013EgonwUsed "PubChem-compound"
40919view22:41, 1 March 2011MaintBotRemoved redundant pathway information and comments
35016view08:26, 11 February 2010ThomasModified description
32280view13:08, 15 August 2009MaintBotFixed text labels
31825view12:25, 14 August 2009MaintBotFixed group labels
31308view20:13, 13 August 2009MaintBotFixed text labels
30786view23:34, 29 July 2009MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
AKR7A2GeneProduct
Aflatoxin B1 8,9-dihydrodiolMetabolite3035008 (PubChem-compound)
Aflatoxin B1 C6-monoalcoholMetabolite
Aflatoxin B1 C6-monoaldehydeMetabolite
Aflatoxin B1 C8-monoalcoholMetabolite
Aflatoxin B1 C8-monoaldehydeMetabolite
Aflatoxin B1 dialdehydeMetabolite
Aflatoxin B1 exo-8,9-epoxide-GSHMetabolite5460816 (PubChem-compound)
Aflatoxin B1 exo-8,9-epoxideMetabolite104756 (PubChem-compound)
Aflatoxin B1-6,8-dialcoholMetabolite
Aflatoxin M1 epoxideMetabolite
Aflatoxin M1Metabolite15558498 (PubChem-compound)
Aflatoxin Q1Metabolite104757 (PubChem-compound)
Aflatoxin-endo-B1-8,9-epoxideMetabolite
CYP2A13GeneProduct
CYP3A4GeneProduct
GSTM1GeneProduct
XP_001489035.1GeneProductENSECAG00000019677 (Ensembl)
XP_001489453.1GeneProductENSECAG00000002100 (Ensembl)
XP_001493936.1GeneProductENSECAG00000008153 (Ensembl)
XP_001917301.1GeneProductENSECAG00000006082 (Ensembl)
aflatoxin B1MetaboliteHMDB06552 (HMDB)

Annotated Interactions

No annotated interactions
Retrieved from "https://oldclassic.wikipathways.org/index.php/Pathway:WP1217"
Personal tools